Rasilez 150mg Tablet FC
By Rasilez
Rx
7 Tablet FC in a Strip

Composition
Aliskiren(150mg)

Manufacturer - Novartis India Ltd
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Expires on or after
April, 2026

liver
When taking Rasilez 150mg Tablet FC, it's important to be cautious if you have severe liver disease. Patients with severe liver issues may require a dosage adjustment while using Rasilez 150mg Tablet FC. It's advisable to consult your doctor before starting or continuing this medication. There is limited information on the use of Rasilez 150mg Tablet FC in patients with liver disease, so it is crucial to follow your healthcare provider's guidance. However, in cases of mild to moderate liver disease, no dose adjustment is typically recommended.

kidney
Rasilez 150mg Tablet FC requires caution in patients with kidney disease. Dosage adjustment may be necessary, and regular monitoring of creatinine and potassium levels is advised. Limited information is available, consult your doctor for guidance.

alcohol
Caution advised when combining alcohol with Rasilez 150mg Tablet FC due to increased drowsiness risk.

driving
When taking Rasilez 150mg Tablet FC, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
During pregnancy, Rasilez 150mg Tablet FC is considered unsafe due to risks to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Rasilez 150mg Tablet FC is likely safe to use while breastfeeding based on limited human data. There appears to be no significant risk to the baby.
Habit Forming | No |
Chemical Class | Delta Amino Acids Derivatives |
Therapeutic Class | - |
Action Class | Renin inhibitors |
₹342.75
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025